Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept (original) (raw)

International Journal of Mycobacteriology, 2016

Abstract

Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.

Tapan Kumar Dhali hasn't uploaded this paper.

Let Tapan Kumar know you want this paper to be uploaded.

Ask for this paper to be uploaded.